Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.

Blood
Susanne SchnittgerWolfgang Kern

Abstract

The BRAFV600E mutation was recently detected in hairy cell leukemia (HCL) by whole exome sequencing. To make use of this new marker for diagnosis and follow-up of HCL, we developed a BRAFV600Emut-specific quantitative real-time PCR assay and validated it in 117 HCL patients and 102 non-HCL/BRAFwt patients. The cut-off level to discriminate BRAFV600E-positive/-negative cases was set at 0.023% BRAFV600E/BRAFwt. A total of 115 of 117 HCL (98.3%) demonstrated percentage BRAFV600E/BRAFwt above the cut-off (mean, 29.6 ± 41.1). The remaining 2 of 117 HCL with lower percentage BRAFV600E/BRAFwt ratios were also BRAFwt by deep-sequencing technology. Sixteen HCL-variant patients showed percentage BRAFV600E/BRAFwt values corresponding to "non-HCL." Follow-up studies in 19 HCL cases demonstrated a decrease of percentage BRAFV600E/BRAFwt during therapy. The log-reductions as determined by RT-PCR and immunophenotyping correlated significantly (P < .001). In conclusion, we confirmed BRAFmut as a useful marker in HCL, its absence in HCL variant, and developed an RT-PCR-based assay to monitor minimal residual disease in HCL.

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Feb 25, 2006·Blood·Farhad RavandiHagop M Kantarjian
May 26, 2006·Nature Reviews. Cancer·Enrico TiacciBrunangelo Falini
May 15, 2008·British Journal of Haematology·Graça M DoresWilliam F Anderson
Oct 22, 2009·Blood·Michael R Grever
Jun 15, 2011·The New England Journal of Medicine·Enrico TiacciBrunangelo Falini

❮ Previous
Next ❯

Citations

Jul 31, 2013·Current Hematologic Malignancy Reports·Robert J Kreitman
May 30, 2014·Science Translational Medicine·Stephen S ChungOmar Abdel-Wahab
May 3, 2014·Pathology Oncology Research : POR·Eszter SáriJudit Demeter
Feb 12, 2014·Leukemia & Lymphoma·Jae H Park, Martin S Tallman
Aug 26, 2014·Expert Review of Hematology·Zheng Z Topp, Alan Saven
Apr 30, 2013·Expert Opinion on Drug Metabolism & Toxicology·Geoffrey T Gibney, Jonathan S Zager
Jun 8, 2015·Current Opinion in Hematology·Latif Salam, Omar Abdel-Wahab
Nov 29, 2015·Best Practice & Research. Clinical Haematology·Sascha Dietrich, Thorsten Zenz
Mar 26, 2014·British Journal of Haematology·Francine Garnache OttouElizabeth Macintyre
Apr 3, 2014·Cancer Science·Mamiko Sakata-YanagimotoShigeru Chiba
Jan 18, 2014·British Journal of Haematology·Sebastian TschernitzEva Geissinger
Jan 22, 2013·Orvosi hetilap·Eszter SáriJudit Demeter
Mar 27, 2015·Der Pathologe·W Klapper, H Kreipe
Feb 6, 2014·Blood Cells, Molecules & Diseases·Marcin M Machnicki, Tomasz Stoklosa
May 9, 2013·Case Reports in Hematology·Stephen E LangabeerPaul V Browne
Mar 19, 2014·The Journal of Experimental Medicine·Marie-Luise BerresCarl E Allen
Jul 5, 2013·Annals of Laboratory Medicine·Hee-Won MoonSung Yong Kim
Aug 25, 2016·Blood·Brunangelo FaliniEnrico Tiacci
Jul 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Preetesh JainFarhad Ravandi
Dec 17, 2014·American Journal of Clinical Pathology·Guldeep UppalJerald Z Gong
Dec 17, 2014·American Journal of Clinical Pathology·Noah A BrownNathanael G Bailey
Feb 21, 2019·Expert Review of Hematology·Mark B GeyerMartin S Tallman
Jun 13, 2019·Hematological Oncology·Brunangelo Falini, Enrico Tiacci
Jan 9, 2013·British Journal of Haematology·Alexander KohlmannTorsten Haferlach
Jul 10, 2019·Expert Review of Clinical Immunology·Margot C E PolderdijkGer T Rijkers
Jun 20, 2014·Journal of Clinical and Experimental Hematopathology : JCEH·Seiji SakataKengo Takeuchi
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Enrico TiacciBrunangelo Falini
Oct 16, 2021·Hematological Oncology·Alessandro BroccoliPier Luigi Zinzani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.